Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
Inoviq LtdTelephone
61.3.9548.7586
Address
23 Normanby Road Notting Hill, Victoria (VIC) 3168
Description
INOVIQ Ltd. is a biotechnology company, which engages in the provision of medical services. It operates through the following geographical segments: Australia, United States of America, and Switzerland. The company was founded on June 30, 1983 and is headquartered in Subiaco, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.47 - 0.92
Trade Value (12mth)
AU$16,242.00
1 week
1.69%
1 month
8.11%
YTD
-11.11%
1 year
-25%
All time high
61.12
EPS 3 yr Growth
36.000%
EBITDA Margin
%
Operating Cashflow
-$7m
Free Cash Flow Return
-28.70%
ROIC
-36.70%
Interest Coverage
-151.60
Quick Ratio
6.20
Shares on Issue (Fully Dilluted)
92m
HALO Sector
Healthcare
Next Company Report Date
27-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
22 July 24 |
EGM Proxy Form
×
EGM Proxy Form |
19 July 24 |
Notice of Extraordinary General Meeting
×
Notice of Extraordinary General Meeting |
09 July 24 |
Application for quotation of securities - IIQ
×
Application for quotation of securities - IIQ |
09 July 24 |
IIQ Options Distribution Schedule and Top 20 Holders
×
IIQ Options Distribution Schedule and Top 20 Holders |
09 July 24 |
Application for quotation of securities - IIQ
×
Application for quotation of securities - IIQ |
05 July 24 |
Successful completion of Share Purchase Plan
×
Successful completion of Share Purchase Plan |
03 July 24 |
Notification of cessation of securities - IIQ
×
Notification of cessation of securities - IIQ |
20 June 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
19 June 24 |
INOVIQ lodges SPP and Options Prospectus
×
INOVIQ lodges SPP and Options Prospectus |
19 June 24 |
Application for quotation of securities - IIQ
×
Application for quotation of securities - IIQ |
12 June 24 |
INOVIQ completes $7m placement
×
INOVIQ completes $7m placement |
12 June 24 |
Investor Presentation
×
Investor Presentation |
12 June 24 |
INOVIQ isolates brain-derived exosomes in Alzheimer's
×
INOVIQ isolates brain-derived exosomes in Alzheimer's |
12 June 24 |
Proposed issue of securities - IIQ
×
Proposed issue of securities - IIQ |
12 June 24 |
Proposed issue of securities - IIQ
×
Proposed issue of securities - IIQ |
12 June 24 |
Update - Proposed issue of securities - IIQ
×
Update - Proposed issue of securities - IIQ |
11 June 24 |
INOVIQ MST Access Investor Presentation
×
INOVIQ MST Access Investor Presentation |
07 June 24 |
Trading Halt
×
Trading Halt |
03 June 24 |
Breakthrough Exosome Therapy
×
Breakthrough Exosome Therapy |
30 April 24 |
Quarterly Activities Report and Appendix 4C - March 2024
×
Quarterly Activities Report and Appendix 4C - March 2024 |
19 April 24 |
Ovarian Cancer Test Validation
×
Ovarian Cancer Test Validation |
17 April 24 |
INOVIQ Investor Update
×
INOVIQ Investor Update |
16 April 24 |
INOVIQ Investor Webinar
×
INOVIQ Investor Webinar |
15 April 24 |
INOVIQ and Promega sign Global EXO-NET Agreement
×
INOVIQ and Promega sign Global EXO-NET Agreement |
12 April 24 |
INOVIQ ShareCafe Investor Presentation
×
INOVIQ ShareCafe Investor Presentation |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.